Insider Transactions in Q1 2025 at Caribou Biosciences, Inc. (CRBU)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 21
2025
|
Barbara G Mcclung Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,564
-0.8%
|
$3,564
$1.35 P/Share
|
|
Feb 21
2025
|
Steven Kanner Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,564
-0.82%
|
$3,564
$1.35 P/Share
|
|
Feb 21
2025
|
Ruhi Ahmad Khan Chief Business Officer |
SELL
Open market or private sale
|
Direct |
3,564
-5.06%
|
$3,564
$1.35 P/Share
|
|
Feb 20
2025
|
Barbara G Mcclung Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
37,500
+7.74%
|
-
|
|
Feb 20
2025
|
Tina M. Albertson Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,589
+50.0%
|
-
|
|
Feb 20
2025
|
Rachel E. Haurwitz President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
136,750
+31.64%
|
-
|
|
Feb 20
2025
|
Steven Kanner Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
37,500
+7.93%
|
-
|
|
Feb 20
2025
|
Timothy P Kelly Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
37,500
+50.0%
|
-
|
|
Feb 20
2025
|
Ruhi Ahmad Khan Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
37,500
+34.72%
|
-
|
|
Jan 29
2025
|
Sriram Ryali Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
17,360
+50.0%
|
$17,360
$1.42 P/Share
|